How changes in Medicare policy affect the use of calcimimetics in dialysis patients
Official title: Incentive Payments and Practice Patterns in Dialysis: The Case of Calcimimetics
Funded at Stanford University · NIH-11024339 · Data updated 2026-11-12
This study looks at how a new Medicare policy that made it easier for dialysis patients to get calcimimetics—medications that help with a condition called secondary hyperparathyroidism—has affected their health and treatment outcomes.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $83,932 |
| NIH project number | 1F32DK141532-01 |
| Project ID | NIH-11024339 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are dialysis patients with end-stage kidney disease who have secondary hyperparathyroidism.
✕Less likely to help
Patients who are not on dialysis or do not have secondary hyperparathyroidism may not benefit from this research.
What this research studies
This research investigates the impact of a Medicare policy change that expanded access to calcimimetics, medications used to treat secondary hyperparathyroidism in dialysis patients. By analyzing data from the United States Renal Data System, the study will compare prescribing patterns of these medications before and after the policy change. The goal is to understand how this change has influenced patient outcomes, including morbidity and mortality rates among those receiving dialysis. This research aims to provide insights into the effectiveness of policy interventions in improving treatment access for patients with end-stage kidney disease.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment access and outcomes for dialysis patients suffering from secondary hyperparathyroidism.
How similar studies have gone: Previous studies have shown that policy changes can significantly impact medication access and patient outcomes, suggesting that this approach has potential for success.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Caldwell, Jillian Scott — Stanford University
- Study coordinator: Caldwell, Jillian Scott
Related research
Other NIH-funded projects on the same topics.
-
How dialysis facility growth affects care for people with end-stage kidney disease
New research will examine whether the spread of dialysis centers and new treatment technologies benefit patients with end-stage kidney disease, and whether benefits reach all communities.
-
MOVE Trial: Tailored motivational support to help African Americans stick with dialysis
A study tests a customized motivational interviewing approach to help African American dialysis patients stay adherent to their treatment, aiming to reduce hospitalizations and improve health.
-
Blood sugar monitoring for people on maintenance dialysis
This project tests how continuous glucose monitoring can better track blood sugar in people on dialysis to improve diabetes care and prevent complications.
-
Quality of life for people on home dialysis and their family caregivers
This grant studies how living with home dialysis affects daily life and the well-being of patients and their family caregivers.
-
Patient-provider conversations and unequal access to home dialysis and kidney transplant
This project explores how conversations between doctors and patients affect why some Black and Hispanic people with kidney disease don’t get home dialysis or preemptive kidney transplants as often as White or Asian patients.
-
CHOOSE Home: Using community health workers to boost home dialysis and social care in CKD
A real-world trial tests adding community health workers to an interdisciplinary CKD clinic to help patients access home dialysis options.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.